Publicacións nas que colabora con Antonio Gil Moreno (21)

2023

  1. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

2022

  1. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

    Oncogene, Vol. 41, Núm. 13, pp. 1835-1850

2021

  1. M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients

    Gynecologic Oncology, Vol. 161, Núm. 3, pp. 681-686

  2. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas

    Biomedicine and Pharmacotherapy, Vol. 140

2020

  1. Genomic profiling of uterine aspirates and cfDNA as an integrative liquid biopsy strategy in endometrial cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. A novel saliva-based mirna signature for colorectal cancer diagnosis

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  2. Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer

    Cancers, Vol. 11, Núm. 12

  3. Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer

    Journal of Proteome Research, Vol. 18, Núm. 3, pp. 1043-1053

2018

  1. ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer

    Oncotarget, Vol. 9, Núm. 24, pp. 16648-16664

  2. Human salivary microRNAs in Cancer

    Journal of Cancer, Vol. 9, Núm. 4, pp. 638-649

2017

  1. Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

    Modern Pathology, Vol. 30, Núm. 1, pp. 134-145

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

  2. Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion

    Clinical and Experimental Metastasis, Vol. 32, Núm. 5, pp. 467-478

2014

  1. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas

    Carcinogenesis, Vol. 35, Núm. 12, pp. 2679-2686

  2. Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

    Molecular Cancer, Vol. 13, Núm. 1

2012

  1. ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas

    Oncogene, Vol. 31, Núm. 45, pp. 4778-4788

  2. Erratum: Molecular markers of endometrial carcinoma detected in uterine aspirates (International Journal of Cancer (2011) 129:11 (2435-2444) DOI: 10.1002/ijc.25901)

    International Journal of Cancer

2011

  1. High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion

    Molecular Cancer Therapeutics, Vol. 10, Núm. 8, pp. 1357-1366

  2. Molecular markers of endometrial carcinoma detected in uterine aspirates

    International Journal of Cancer, Vol. 129, Núm. 10, pp. 2435-2444

2009

  1. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress

    Carcinogenesis, Vol. 30, Núm. 8, pp. 1288-1297